Anthropic spent $400 million to acquire a company with fewer than 10 people The company is called Coefficient Bio, founded just last year, and the team is entirely made up of computational biology experts from Genentech. $400M for 10 people? Crazy, right? Not crazy. They're investing in the AI + biotech direction. Dario (Anthropic CEO) has a big goal: getting Claude involved in drug development. In January, they launched Claude for Life Sciences, integrating with research platforms like PubMed and Benchling. Now they've brought the talent onboard too. Basically: AI isn’t just here to help you write copy anymore—it’s here to help make medicine. Here’s the kicker—Anthropic’s IPO is coming soon. Acquiring a biotech team instantly upgrades their narrative: from "chatbot company" to "AI research infrastructure." The ceiling is on a whole different level.